Clinical Trials on Infecciones bacterianas grampositivas

Total 56388 results

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Air Force Military Medical University, China; Jiangsu Province Centers for... and other collaborators

Completed

Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy)

Tuberculosis
Bavarian Nordic

Completed

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Respiratory Syncytial Virus Infections

United States
Weill Medical College of Cornell University

Completed

A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis

Tuberculosis

Haiti
Dignitas International
Unity Health Toronto

Completed

Training Lay Healthcare Workers to Optimize TB Care and Improve Outcomes in Malawi

Tuberculosis

Malawi
Nearmedic Plus LLC
OCT LLC

Terminated

Phase 2a Study of PBTZ169

Tuberculosis
Fundació Institut Germans Trias i Pujol
National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia

Completed

Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis (NSAIDS-XDRTB)

Tuberculosis

Georgia, South Africa
National Institute of Allergy and Infectious Diseases...
Korean Center for Disease Control and Prevention; International Tuberculosis... and other collaborators

Completed

Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis

Tuberculosis

Korea, Republic of
Global Alliance for TB Drug Development

Completed

PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)

Tuberculosis

United States
Aeras
Sanofi Pasteur, a Sanofi Company

Completed

Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents

Tuberculosis

South Africa
Children's Healthcare of Atlanta

Completed

Music Therapy With Intubated and Sedated Pediatric Patients

Respiratory Syncytial Virus Infections

United States
Immunitor LLC
University of Stellenbosch; Lisichansk Regional Tuberculosis Dispensary; National... and other collaborators

Completed

TB Immunotherapy Trial With Heat-killed M. Vaccae (imm03)

Tuberculosis

Mongolia, Ukraine
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
Chinese University of Hong Kong

Completed

Application of GeneXpert on Bronchoscopic Samples in the Clinical Management of Patients Suspicious of TB

Tuberculosis

Hong Kong
University of Alabama at Birmingham

Withdrawn

Tuberculosis Diagnosis by Flow Cytometry

Tuberculosis

Zambia
University of Oxford

Completed

RSV Observational Study 2

Respiratory Syncytial Virus Infections

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age

Respiratory Syncytial Virus Infections

United States
Johns Hopkins University
Boston Medical Center

Completed

Feasibility and Accuracy of a Novel Xpert Cartridge ((XpertDST))

Tuberculosis
National Institute of Allergy and Infectious Diseases...

Terminated

Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Respiratory Syncytial Virus Infections

United States
Global Alliance for TB Drug Development

Completed

A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects. (CL-004)

Tuberculosis

United States
GlaxoSmithKline

Completed

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Respiratory Syncytial Virus Infections

United States, Australia, Germany, Czechia
Michael Hoelscher

Completed

Establishment of a Clinical Trial Unit in Mavalane, Maputo, in Mozambique (MaTuTU)

Tuberculosis

Mozambique
Gamaleya Research Institute of Epidemiology and...

Completed

Evaluation of the Safety and Immunogenicity of the Recombinant Subunit Vaccine "GamTBvac" Against the Tuberculosis. (GamTBvac)

Tuberculosis

Russian Federation
Harvard University Faculty of Medicine
National Institute of Allergy and Infectious Diseases (NIAID); Sanofi; University... and other collaborators

Completed

Trial of High-Dose Rifampin in Patients With TB (HIRIF)

Tuberculosis

United States, Peru, United Kingdom
Alios Biopharma Inc.

Completed

A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176

Respiratory Syncytial Virus Infections

United Kingdom
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus

Respiratory Syncytial Virus Infections

Australia, Singapore, United States, New Zealand, Taiwan
National Institute of Allergy and Infectious Diseases...

Completed

Safety, Tolerability, and Immunogenicity of the Vaccine Candidates ID93 + AP10-602 and ID93 + GLA-SE Administered Intramuscularly in Healthy Adult Subjects

Tuberculosis

United States
McGill University
World Bank; Institute of Socio-Economic Research on Development and Democracy... and other collaborators

Completed

Quality of Tuberculosis Care in Mumbai, India

Tuberculosis
Swiss Federal Institute of Technology
Swiss Tropical & Public Health Institute; Ifakara Health Institute

Completed

Iron Absorption and Utilization During Tuberculosis and After Treatment

Tuberculosis

Tanzania
University of Edinburgh
NHS Lothian

Completed

Virtual Observed Therapy for Patients With Tuberculosis

Tuberculosis

United Kingdom
National University Hospital, Singapore

Completed

Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers

Tuberculosis

Singapore
National University Hospital, Singapore

Suspended

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers

Tuberculosis

Singapore
National University Hospital, Singapore

Completed

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers

Tuberculosis

Singapore
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Shanghai Public Health Clinical Center; Air Force Military Medical University... and other collaborators

Completed

Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10

Tuberculosis
McGill University
World Bank; Institute of Socio-Economic Research on Development and Democracy... and other collaborators

Completed

Quality of Tuberculosis Care in Urban Patna, India

Tuberculosis
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States
Novavax

Completed

RSV F Dose-Ranging Study in Women

Respiratory Syncytial Virus Infections

United States
University of Oxford
University of Birmingham

Completed

Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults

Tuberculosis

United Kingdom
Statens Serum Institut

Completed

A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI

Tuberculosis

South Africa
Epicentre
Mbarara University of Science and Technology; Medecins Sans Frontieres, Netherlands

Completed

An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, Uganda

Tuberculosis
Epicentre
Mbarara University of Science and Technology; Medecins Sans Frontieres, Netherlands

Completed

Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda (TBcontact)

Tuberculosis
Global Alliance for TB Drug Development

Completed

Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-003)

Tuberculosis

United States
NYU Langone Health

Withdrawn

Tuberculosis Research Blood Bank

Tuberculosis

United States
Research Center Borstel
Alere Technologies GmbH

Completed

Alere Mycobacterium Tuberculosis Urine Study

Tuberculosis

Germany
Aeras
University of Rochester

Completed

Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US

Tuberculosis
The Behavioural Insights Team

Unknown

Virtually Observed Treatment (VOT) for Tuberculosis Patients in Moldova

Tuberculosis
Gilead Sciences

Completed

Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) (Challenge)

Respiratory Syncytial Virus Infections

United Kingdom
Statens Serum Institut

Completed

Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI

Tuberculosis

Spain
Harvard School of Public Health (HSPH)
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis

Tuberculosis

Tanzania
St George's Healthcare NHS Trust

Unknown

Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum (MDRTB01)

Tuberculosis

United Kingdom

Clinical Trials on Infecciones bacterianas grampositivas

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations